1. 000216 ABERRANT P53 IMMUNOSTAINING AS A PROGNOSTIC FACTOR IN EPITHELIAL OVARIAN CANCER; THE IMPACT OF METHODOLOGY. (1st September 2005) Authors: De Graeff, P.; Hall, J.; Crijns, A. P.G.; De Bock, G. H.; Gifford, G.; Paul, J.; De Jong, S.; Bartlett, J. M.; Brown, R.; J. Van Der Zee, A. G. Journal: International journal of gynecological cancer Issue: Volume 15(2005)Supplement 2 Page Start: 111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Characteristics of Lynch Syndrome Associated Ovarian Cancer. Issue 9 (September 2018) Authors: Woolderink, J. M.; De Bock, G. H.; de Hullu, J. A.; Hollema, H.; Zweemer, R. P.; Slangen, B. F. M.; Gaarenstroom, K. N.; van Beurden, M.; van Doorn, H. C.; Sijmons, R. H.; Vasen, H. F. A.; Mourits, M. J. E. Journal: Obstetrical & gynecological survey Issue: Volume 73:Issue 9(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The clinical value and the cost-effectiveness of follow-up in endometrial cancer patients. Issue 5 (8th September 2005) Authors: Dijkstra, J. R.; De Bock, G. H.; Mourits, M. J.E. Journal: International journal of gynecological cancer Issue: Volume 15:Issue 5(2005) Page Start: 991 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗